Lantheus is expanding its holdings of PET imaging agents for Alzheimer’s disease, with the acquisition of Meilleur Technologies. The deal grants Lantheus exclusive worldwide rights to Meilleur’s radiopharmaceutical diagnostic that highlights beta amyloid plaques in the brain. The injectable agent is currently in phase 3 development. Read more below: https://lnkd.in/eBU-c58q #acquisition #medtech #medtechnews
Mantell Associates
Executive Search Services
City of London, England 76,700 followers
Multidiscipline Global Life Science and Pharmaceutical Headhunting Firm.
About us
Mantell Associates is a multi-discipline headhunting firm focused on providing both permanent and contract recruitment services globally, to the Biotech, Pharmaceutical, CDMO, CRO, Diagnostics, Animal Health, Consulting, Medical Device and MedTech sectors. With success ranging across C-Suite, Commercial, Technical Operations, Scientific, Clinical, Quality and Regulatory, we pride ourselves on our ability to bring the top talent to our clients, and the best opportunities to the top talent. Our services span across our Partnership Service, Contingency, Project Management and Contract models, meaning that we can cater to our client’s every requirement.
- Website
-
www.mantellassociates.com
External link for Mantell Associates
- Industry
- Executive Search Services
- Company size
- 51-200 employees
- Headquarters
- City of London, England
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Contract Development Manufacturing Organisations, Contract Manufacturing Organisations, Preclinical, Active Pharmaceutical Ingredients, Cell & Gene Therapy, Finished Dosage Forms, Biologics, Toxicology, Pharmacology, Oncology, CDMO, CMO, Biomarkers, Vaccines, Contract Research Organisation, Clinical Trial Supplies, Bioanalytics, Bioanalysis, Fine Chemicals, and Highly Potent Active Pharmaceutical Ingredients
Locations
-
Primary
150 Minories
City of London, England EC3N 1LS, GB
-
2 S Biscayne Blvd
Miami, Florida 33131, US
-
Rigistrasse 3
Zug, 6300, CH
Employees at Mantell Associates
Updates
-
Listen to what our clients and candidates have said about us... "Huseyin was a pleasure to work with while he placed me in my current position. He negotiated a deal that allowed my family and I to move across the country." Get in touch with Huseyin Pulat on +44 (0)20 3854 7700. #testimonialtuesday #pharmarecruitment #lifesciencerecruitment
-
Merck, known as MSD outside of the USA and Canada, has completed the previously announced acquisition of Eyebiotech Limited (EyeBio). EyeBio is now a wholly-owned subsidiary of Merck. Read more below: https://lnkd.in/et7R6xCS #acquisition #biotech #biotechnews
Merck Completes Acquisition of EyeBio
contractpharma.com
-
Pfizer has dragged the oral GLP-1 candidate danuglipron back from the brink. Months after dropping one version of the asset, the Big Pharma has vowed to advance a once-daily, modified-release formulation on the strength of “encouraging pharmacokinetic data.” Read more below: https://lnkd.in/e94nSPKC #obesitydrugs #drugdevelopment #drugtrials
Pfizer bounces back in obesity, moving once-daily oral drug toward pivotal trials after earlier missteps
fiercebiotech.com
-
Thermo Fisher Scientific announced on 10 July that it has completed its acquisition of Olink Proteomics, a leading provider of next-generation proteomics solutions. The transaction values Olink at approximately $3.1 billion, net of $96 million of acquired cash. Olink will become part of Thermo Fisher's Life Sciences Solutions segment. https://lnkd.in/e2WWGRsP #acquisition #proteomics #lifesciences
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
ir.thermofisher.com
-
New opportunity! Quality System Engineer - Medical Devices - France. Mantell Associates is currently partnered with an innovative Medical Devices organisation, who are seeking a Quality System Engineer to join their team. Apply for this role directly online - https://lnkd.in/eBgEDdJe - or contact Sharleney Chandraratna. #qualityjobs #engineerjobs #medicaldevices
-
What a day at the MA Summer Party in London! Our UK team celebrated a fantastic first half of 2024 at the new Florattica Rootfop, with an afternoon of drinks, music, good food and even better company. In H1, our focus was on creating a winning culture and getting the right people into the business. Looking ahead to the rest of the year, H2 is about striving to break records! Huge thanks to our CEO Alessandro Mantell for a great afternoon and the opportunity to celebrate as a team, here's to the rest of 2024! #recruitmentlondon #recruitmentincentives #summerparty
-
Mantell Associates reposted this
Join us September 3-6th, 2024 at Parsippany Hilton, New Jersey for ChemOutsorcing Week, a new expanded format to give buyers more options to attend the show. A full week of client meetings you tailor to suit your needs and availability. Visit www.chemoutsourcing.com for more information. For injuries, please email [email protected]
This content isn’t available here
Access this content and more in the LinkedIn app
-
What's next for oncology? Christian Lopez discusses how oncology, the branch of medicine dedicated to the diagnosis, treatment, and research of cancer, has seen significant advancements and shifts over the past five years. Read more below: https://lnkd.in/eB5J8nHK #oncology #futureoncology #cancertreatment
Reviewing the Past 5 Years in Oncology - What's Next?
mantellassociates.com
-
Despite letting go of Grail last month, Illumina isn’t shying away from M&A. The DNA sequencing giant has now acquired Fluent BioSciences Inc. to expand its reach in single-cell analysis and multiomics research. Read more below: https://lnkd.in/g2YM3UGP #celltherapy #bioscience #pharmanews
Illumina buys Fluent BioSciences to better speak the language of single-cell analysis
fiercebiotech.com